Clinical Trial

Magnesium and Cognition After Stroke

Recruiting
View on ClinicalTrials.gov →
Summary
Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients. Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until now, no studies investigating the relationship between mg-concentration, stroke severity and cognition during treatment course are available. Thus, this study aimed to investigate the relationship between mg-concentration and cognition of stroke patients.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-11-19; most recent amendment 2026-04-16.
Status change: Not Yet Recruiting → Recruiting 2022-10-07
Trial Details
NCT Number NCT05132517
Lead Sponsor BDH-Klinik Hessisch Oldendorf
Conditions Stroke, Cognition, Magnesium, Neurologic Disorder
Enrollment 80 participants
Start Date 2022-10-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20